Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Functional Piezoelectric Nano Composite Fibers for Smart Drug Delivery

Project description

Mechano-responsive drug delivery

To enhance the therapeutic effectiveness of drugs and minimise any potential side effects, there is a need for controlled drug delivery systems. Funded by the Marie Skłodowska-Curie Actions programme, the SMRT-DRUG-DLVR project proposes to exploit piezoelectric materials for drug delivery due to their ability to convert mechanical forces into electric potentials. Researchers will use iron-based nanofibres as drug delivery platforms. The properties of these materials are expected to reduce fabrication complexity and cost and generate a novel drug delivery system that responds to mechanical pressure. These nanofibres have the potential to find applications beyond biomedicine in wearable technologies.

Objective

The development of controlled drug delivery systems has been extensively investigated to improve the therapeutic efficacy of conventional drug products. The control over biodistribution and pharmacokinetics is critical to enhance the efficacy and minimizing the side effects of therapeutic agents. An on-demand drug delivery system for precise control over the release time and the quantity of drugs is needed which has not been studied comprehensively and remains to be explored. Piezoelectric materials provide a superior platform for the electrically controlled drug delivery system due to their ability in converting mechanical forces to electric potentials through the direct piezoelectric effect. The importance of this project is the contribution of the piezoelectric effect on drug loading and release. This project proposes the mechanoresponsiveness of piezoelectric electrospun nanocomposite fibers for drug delivery applications. The novelty of the project is adding two-dimensional (2D) ferroelectric nanofillers to the composite to enhance piezoelectric efficiency which leads eliminating additional post-treatment processes (poling) reducing fabrication complexity and cost. The large surface area inherent to nanomaterials, fiber’s porosity, together with the transformative piezoelectric properties, allow electrospun fiber to be a drug delivery platform driven by the piezoelectric effect. The drug release quantity will be tuned by a mechanical stimulus in in-vitro conditions. This project will demonstrate the utility of piezoelectric nanocomposite electrospun fiber for mechano-responsive controlled drug release and its potential for in-vivo applications in a facile manner in the future.
Ten years of experience and knowledge in functional fibers that come to this project by the applicant will strengthen the KU Leuven lead in smart fibers based on piezoelectric materials for a wide range of applications not only in biomedical applications but also in wearable technology.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2022-PF-01

See all projects funded under this call

Coordinator

KATHOLIEKE UNIVERSITEIT LEUVEN
Net EU contribution
€ 191 760,00
Address
OUDE MARKT 13
3000 Leuven
Belgium
Region
Vlaams Gewest Prov. Vlaams-Brabant Arr. Leuven
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data